NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)

This grant supports rapid translation of innovative laboratory findings into therapeutics for visual system diseases, funding product development of biological, pharmaceutical, medical device, or combination therapies. The R61 phase backs early pre-clinical work with strong preliminary data, while the R33 phase advances a single candidate through IND/IDE studies and preparation for clinical trials.

Amount: Not stated
Type: Grant

Key facts

Key facts for NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
Amount	Not stated
Issuer	National Institutes of Health
Who can apply	Small businesses, companies, universities and 7 more
Sectors	HealthTech
Deadline	Closes 16 Nov 2029

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked just now

10 days agoagentImported from the official source

Opportunities with the same funding type or region
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)		Closes 20 Jun 2029
Human-Environment and Geographical Sciences Program (HEGS)		Closes 15 Jan 2027
National Digital Newspaper Program	up to $325,000	Closes 13 Jan 2027